CROHN'S DISEASE (CD)
Clinical trials for CROHN'S DISEASE (CD) explained in plain language.
Never miss a new study
Get alerted when new CROHN'S DISEASE (CD) trials appear
Sign up with your email to follow new studies for CROHN'S DISEASE (CD), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Immune cell therapy takes on stubborn IBD
Disease control Not yet recruitingThis early-phase study tests a new treatment called RD06-05, which uses specially engineered immune cells (CAR-T cells) to target and calm the overactive immune system in people with moderate-to-severe ulcerative colitis or Crohn's disease. The study includes up to 30 adults who …
Matched conditions: CROHN'S DISEASE (CD)
Phase: EARLY_PHASE1 • Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology • Aim: Disease control
Last updated May 14, 2026 12:06 UTC
-
New hope for Crohn's patients: drug may stop disease return after surgery
Prevention Not yet recruitingThis study looks at whether the drug guselkumab can prevent Crohn's disease from returning after bowel surgery. About 88 adults with moderate to severe Crohn's who have had surgery will receive guselkumab and be monitored for 48 weeks. The main goal is to see if the disease stays…
Matched conditions: CROHN'S DISEASE (CD)
Sponsor: Shanghai 10th People's Hospital • Aim: Prevention
Last updated May 12, 2026 13:42 UTC